Rapid Communication
Copyright ©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 14, 2007; 13(2): 294-298
Published online Jan 14, 2007. doi: 10.3748/wjg.v13.i2.294
Table 1 Characteristics of patients and controls (mean ± SD)
CharacteristicPatient group(n = 38)Control group(n = 40)P
Age (yr)41.1 ± 10.3 a34.2 ± 14.20.017
Male/Female30/8 b20/200.010
BMI (kg/m2)24.8 ± 4.724.3 ± 4.90.691
Smoking n (%)25 (65.8) b3 (7.5)< 0.001
Alcohol n (%)6 (15.8)1 (2.5)0.054
History of iv drug use n (%)9 (23.7) b0 (0)0.001
Table 2 Characteristics of hepatitis C patients according to vaccine response (mean ± SD)
CharacteristicsNon-responder(n = 10)Responder(n =28)P
Age (yr)41.5 ± 11.341.0 ± 10.20.897
Male/Female8/222/61.000
BMI (kg/m2)26.6 ± 6.024.2 ± 4.10.192
Smoking n (%)9 (90.0)16 (57.1)0.118
Alcohol n (%)2 (20.0)4 (14.3)0.644
Hx of iv drug use n (%)2 (20.0)7 (25.0)1.000
ALT (IU/L)177.1 ± 293.978.3 ± 165.30.199
Liver disease
HAI grade (0-18)15.4 ± 2.15.6 ± 1.90.773
HAI stage (0-6)12.3 ± 1.12.6 ± 1.60.669
HCV genotype n (%)826
1a6 (75.0)14 (53.8)0.422
Other than 1a2 (25.0)12 (46.2)
Table 3 Characteristics of hepatitis C patients according to vaccine response
CharacteristicNon-responder(n = 10)Low-responder(n = 8)High-responder(n = 20)P
Age (yr)41.5 ± 11.346.1 ± 9.039.0 ± 10.10.394
Male/Female8/25/317/30.417
BMI (kg/m2)26.6 ± 6.024.9 ± 3.023.8 ± 4.60.903
Smoking n (%)9 (90.0)4 (50.0)12 (60.0)0.150
Alcohol n (%)2 (20.0)0 (0)4 (20.0)0.387
Hx of iv drug use n (%)2 (20.0)2 (25.0)5 (25.0)0.950
ALT (IU/L)177.1 ± 293.9149.8 ± 304.649.8 ± 40.30.711
Liver disease
HAI grade (0-18)5.4 ± 2.15.4 ± 2.85.7 ± 1.30.607
HAI stage (0-6)2.3 ± 1.12.4 ± 1.82.7 ± 1.50.986
HCV genotype n (%)8818
1a6 (75.0)a7 (87.5)a7 (38.9)a0.038
Other than 1a2 (25.0)1 (12.5)11 (61.1)